These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 33881612)

  • 21. Profiling TREM2 expression in amyotrophic lateral sclerosis.
    Jericó I; Vicuña-Urriza J; Blanco-Luquin I; Macias M; Martinez-Merino L; Roldán M; Rojas-Garcia R; Pagola-Lorz I; Carbayo A; De Luna N; Zelaya V; Mendioroz M
    Brain Behav Immun; 2023 Mar; 109():117-126. PubMed ID: 36681358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation.
    Moutinho M; Coronel I; Tsai AP; Di Prisco GV; Pennington T; Atwood BK; Puntambekar SS; Smith DC; Martinez P; Han S; Lee Y; Lasagna-Reeves CA; Lamb BT; Bissel SJ; Nho K; Landreth GE
    Genome Med; 2023 Feb; 15(1):11. PubMed ID: 36805764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble TREM2 Concentrations in the Cerebrospinal Fluid Correlate with the Severity of Neurofibrillary Degeneration, Cognitive Impairment, and Inflammasome Activation in Alzheimer's Disease.
    Španić Popovački E; Babić Leko M; Langer Horvat L; Brgić K; Vogrinc Ž; Boban M; Klepac N; Borovečki F; Šimić G
    Neurol Int; 2023 Jul; 15(3):842-856. PubMed ID: 37489359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study.
    Ma LZ; Tan L; Bi YL; Shen XN; Xu W; Ma YH; Li HQ; Dong Q; Yu JT
    Mol Neurodegener; 2020 Apr; 15(1):25. PubMed ID: 32276587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau.
    Henjum K; Quist-Paulsen E; Zetterberg H; Blennow K; Nilsson LNG; Watne LO
    J Neuroinflammation; 2018 Nov; 15(1):304. PubMed ID: 30390679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Cerebrospinal Fluid Soluble TREM2 and Polymorphisms in Sporadic Parkinson's Disease in a Chinese Population.
    Peng G; Qiu J; Liu H; Zhou M; Huang S; Guo W; Lin Y; Chen X; Li Z; Li G; Zhang W; Zhang Y; Li X; Wu Z; Wei L; Yang X; Zhu X; Mo M; Xu P
    J Mol Neurosci; 2020 Feb; 70(2):294-301. PubMed ID: 31833018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.
    Llorens F; Thüne K; Tahir W; Kanata E; Diaz-Lucena D; Xanthopoulos K; Kovatsi E; Pleschka C; Garcia-Esparcia P; Schmitz M; Ozbay D; Correia S; Correia Â; Milosevic I; Andréoletti O; Fernández-Borges N; Vorberg IM; Glatzel M; Sklaviadis T; Torres JM; Krasemann S; Sánchez-Valle R; Ferrer I; Zerr I
    Mol Neurodegener; 2017 Nov; 12(1):83. PubMed ID: 29126445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
    Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
    Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases.
    Llorens F; Villar-Piqué A; Schmitz M; Diaz-Lucena D; Wohlhage M; Hermann P; Goebel S; Schmidt I; Glatzel M; Hauw JJ; Sikorska B; Liberski PP; Riggert J; Ferrer I; Zerr I
    Neuropathol Appl Neurobiol; 2020 Apr; 46(3):240-254. PubMed ID: 31216593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triggering receptor expressed on myeloid cells-2 is involved in prion-induced microglial activation but does not contribute to prion pathogenesis in mouse brains.
    Zhu C; Herrmann US; Li B; Abakumova I; Moos R; Schwarz P; Rushing EJ; Colonna M; Aguzzi A
    Neurobiol Aging; 2015 May; 36(5):1994-2003. PubMed ID: 25816748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease.
    Wang L; Nykänen NP; Western D; Gorijala P; Timsina J; Li F; Wang Z; Ali M; Yang C; Liu M; Brock W; Marquié M; Boada M; Alvarez I; Aguilar M; Pastor P; Ruiz A; Puerta R; Orellana A; Rutledge J; Oh H; Greicius MD; Le Guen Y; Perrin RJ; Wyss-Coray T; Jefferson A; Hohman TJ; Graff-Radford N; Mori H; Goate A; Levin J; Sung YJ; Cruchaga C
    Mol Neurodegener; 2024 Jan; 19(1):1. PubMed ID: 38172904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau.
    Wilson EN; Swarovski MS; Linortner P; Shahid M; Zuckerman AJ; Wang Q; Channappa D; Minhas PS; Mhatre SD; Plowey ED; Quinn JF; Zabetian CP; Tian L; Longo FM; Cholerton B; Montine TJ; Poston KL; Andreasson KI
    Brain; 2020 Mar; 143(3):932-943. PubMed ID: 32065223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.
    Schmitz M; Villar-Piqué A; Hermann P; Escaramís G; Calero M; Chen C; Kruse N; Cramm M; Golanska E; Sikorska B; Liberski PP; Pocchiari M; Lange P; Stehmann C; Sarros S; Martí E; Baldeiras I; Santana I; Žáková D; Mitrová E; Dong XP; Collins S; Poleggi A; Ladogana A; Mollenhauer B; Kovacs GG; Geschwind MD; Sánchez-Valle R; Zerr I; Llorens F
    Brain; 2022 Apr; 145(2):700-712. PubMed ID: 35288744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble TREM2 inhibits secondary nucleation of Aβ fibrillization and enhances cellular uptake of fibrillar Aβ.
    Belsare KD; Wu H; Mondal D; Bond A; Castillo E; Jin J; Jo H; Roush AE; Pilla KB; Sali A; Condello C; DeGrado WF
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35082148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble triggering receptor expressed on myeloid cells 2 (sTREM2) positively regulates lipopolysaccharide-induced expression of CXC chemokine ligand 10 and 11 in mouse macrophages.
    Bandow K; Smith A; Garlick J
    Biochem Biophys Res Commun; 2022 Dec; 635():227-235. PubMed ID: 36283335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum.
    Rauchmann BS; Schneider-Axmann T; Alexopoulos P; Perneczky R;
    Neurobiol Aging; 2019 Feb; 74():182-190. PubMed ID: 30458365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropathologically directed profiling of PRNP somatic and germline variants in sporadic human prion disease.
    McDonough GA; Cheng Y; Morillo KS; Doan RN; Zhou Z; Kenny CJ; Foutz A; Kim C; Cohen ML; Appleby BS; Walsh CA; Safar JG; Huang AY; Miller MB
    Acta Neuropathol; 2024 Jul; 148(1):10. PubMed ID: 39048735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglial Reactivity Correlates with Presynaptic Loss Independent of β-Amyloid and Tau.
    Lan G; Chen X; Yang J; Sun P; Cai Y; Li A; Zhu Y; Liu Z; Ma S; Guo T;
    Ann Neurol; 2024 May; 95(5):917-928. PubMed ID: 38356322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function.
    Schlepckow K; Kleinberger G; Fukumori A; Feederle R; Lichtenthaler SF; Steiner H; Haass C
    EMBO Mol Med; 2017 Oct; 9(10):1356-1365. PubMed ID: 28855300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble Trem2 is a negative regulator of erythrophagocytosis after intracerebral hemorrhage in a CD36 receptor recycling manner.
    Zhou H; Li J; Hu L; Yu J; Fu X; Liang F; Yan F; Chen G
    J Adv Res; 2023 Feb; 44():185-199. PubMed ID: 36725189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.